SMS Pharmaceuticals Ltd. share price target and research reports

Name: Latest research reports of SMS Pharmaceuticals Ltd. authored by Karvy and published by - Trendlyne research reports.
Item: SMS Pharmaceuticals Ltd.
Rating: 3
Author: Karvy

Latest analyst research reports with target prices and PDF download for SMSPHARMA, BSE:532815 SMS Pharmaceuticals Ltd.

Search Inside the pdf :

SMS Pharmaceuticals Ltd.

04 Mar 2025

386.15

-4.55%

SMS Pharmaceuticals | Plant Visit Note

Not Rated: SMS Pharmaceuticals Ltd.

Edelweiss

Ibuprofen to accelerate growth

SMS Pharmaceuticals has gained 26.09% in the last 3 Months

SMS Pharmaceuticals Ltd.

09 Jul 2015

386.15

-4.55%

SMS Pharmaceuticals Ltd: Stable Stage Post Volatility; Future Plans to Unfold (Jul 09, 2015)

Hold: SMS Pharmaceuticals Ltd.

Karvy

Scaled up base portfolio: The company has a base portfolio in long standingGastrointestinal and Antimigraine accounting for close to 40% of existing portfolio.Operating in such long standing therapies, the company delivered Rs. 5000 Mn inrevenues in FY14 (111% YoY) and sustained the scale with 12% growth in FY15.

SMS Pharmaceuticals has gained 26.09% in the last 3 Months

Is SMS Pharmaceuticals Ltd. worth buying?

88 Votes:

Buy 84.09%

Sell 11.36%

Hold 4.55%